✦ LIBER ✦

Gemcitabine (GEM) plus oxaliplatin, folinic acid, and 5-fluorouracil (FOLFOX-4) in patients with advanced gastric cancer

✍ Scribed by Pierpaolo Correale; Fabio Fulfaro; Stefania Marsili; Giuseppe Cicero; Eugenia Bajardi; Chiara Intrivici; Giuseppe Vuolo; Antonio Ferdinando Carli; Michele Caraglia; Salvatore Del Prete; Ettore Greco; Nicola Gebbia; Guido Francini

Book ID: 105992338
Publisher: Springer
Year: 2005
Tongue: English
Weight: 194 KB
Volume: 56
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-005-1024-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A phase II study of biweekly oxaliplatin

A phase II study of biweekly oxaliplatin plus infusional 5-fluorouracil and folinic acid (FOLFOX-4) as first-line treatment of advanced gastric cancer patients

✍ De Vita, F; Orditura, M; Matano, E; Bianco, R; Carlomagno, C; Infusino, S; Damia 📂 Article 📅 2005 🏛 Nature Publishing Group 🌐 English ⚖ 98 KB

Etoposide, folinic acid, and 5-fluoroura

Etoposide, folinic acid, and 5-fluorouracil in carboplatin-pretreated patients with advanced gastric cancer

✍ Hansjochen Wilke; Peter Preusser; Michael Stahl; Andreas Harstrick; Hans-Joachim 📂 Article 📅 1991 🏛 Springer 🌐 English ⚖ 183 KB

A phase II study of irinotecan plus chro

A phase II study of irinotecan plus chronomodulated oxaliplatin, 5-fluorouracil and folinic acid in advanced colorectal cancer patients

✍ Garufi, C; Bria, E; Vanni, B; Zappalà, A M R; Sperduti, I; Terzoli, E 📂 Article 📅 2003 🏛 Nature Publishing Group 🌐 English ⚖ 117 KB

Randomized phase III Study of 5-fluorour

Randomized phase III Study of 5-fluorouracil plus high dose folinic acid versus 5-fluorouracil plus folinic acid plus methyl-lomustine for patients with advanced colorectal cancer

✍ Dennie V. Jones; Roger J. Winn; Barry W. Brown; Lawrence B. Levy; Reginald P. Pu 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 501 KB

Background. Metastatic colorectal cancer is generally incurable. The most active regimen available, 5-fluorouracil(5-FU) and folinic acid (Leucovorin), produces response rates of approximately 25% to 30%. Methyl-lomustine is a nitrosourea with modest activity against colorectal cancer. A randomized

A novel biweekly multidrug regimen of ge

A novel biweekly multidrug regimen of gemcitabine, oxaliplatin, 5-fluorouracil (5-FU), and folinic acid (FA) in pretreated patients with advanced colorectal carcinoma

✍ Correale, P; Messinese, S; Caraglia, M; Marsili, S; Piccolomini, A; Petrioli, R; 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Oxaliplatin/fluorouracil/leucovorin (FOL

Oxaliplatin/fluorouracil/leucovorin (FOLFOX4 and modified FOLFOX6) in patients with refractory or advanced colorectal cancer: post-approval Japanese population experience

✍ Toshio Shimizu; Taroh Satoh; Kenji Tamura; Tomohiro Ozaki; Isamu Okamoto; Masahi 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 259 KB